SEC Form 4 · accession 0001104659-18-072894
Amphastar Pharmaceuticals, Inc. · AMPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Period of report
Dec 11, 2018
Accepted (ET)
Dec 13, 2018 · 8:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001297184
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 11, 2018 | S | 63,504 | $21.4342 | D | 7,398,090 | D | |
| Common StockF2 | Dec 11, 2018 | S | 3,253 | $22.1311 | D | 7,394,837 | D | |
| Common StockF3 | Dec 12, 2018 | S | 37,469 | $21.2105 | D | 7,357,368 | D | |
| Common StockF4 | Dec 13, 2018 | S | 29,689 | $20.9898 | D | 7,327,679 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.055 to $22.05, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1), (2), (3) and (4) to this Form 4.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.055 to $22.27, inclusive.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.93 to $21.54, inclusive.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.83 to $21.28, inclusive.
Remarks
Exhibit 24 - Power of Attorney